Paper · 648762
Anti-insulin receptor antibodies inhibit insulin binding and stimulate glucose metabolism in skeletal muscle.
Le Marchand-Brustel Y and 4 others. Diabetologia, 1978. Cited by 45 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Anti-insulin receptor antibodies inhibit insulin binding and stimulate glucose metabolism in skeletal muscle. Papers, record 648762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/648762
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-insulin receptor antibodies inhibit insulin binding and stimulate glucose metabolism in skeletal muscle.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autoantibodies | Major topic |
| Glucose | Major topic |
| Muscles | Major topic |
| Animals | |
| Biological Transport | |
| Glycogen | |
| Glycolysis | |
| Insulin Resistance | |
| Male | |
| Mice | |
| Mice, Obese | |
| Receptor, Insulin |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,137,321 | Thyroid-stimulating immunoglobulins in Graves' disease. | Lancet | 1974 | https://conductscience.org/library/papers/4137321 | PubMed |
| 2 | 206,148 | Insulin binding and effects in isolated soleus muscle of lean and obese mice. | Am J Physiol | 1978 | https://conductscience.org/library/papers/206148 | PubMed |
| 3 | 993,353 | Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man. | J Clin Invest | 1976 | https://conductscience.org/library/papers/993353 | PubMed |
| 4 | 993,331 | Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice. | J Clin Invest | 1976 | https://conductscience.org/library/papers/993331 | PubMed |
| 5 | 176,581 | The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. | N Engl J Med | 1976 | https://conductscience.org/library/papers/176581 | PubMed |
| 6 | 893,677 | Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes. | J Clin Invest | 1977 | https://conductscience.org/library/papers/893677 | PubMed |
| 7 | 1,069,300 | Direct method for detection and characterization of cell surface receptors for insulin by means of 125I-labeled autoantibodies against the insulin receptor. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1069300 | PubMed |
| 9 | 170,678 | Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. | Science | 1975 | https://conductscience.org/library/papers/170678 | PubMed |
| 10 | 908,753 | Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action. | J Clin Invest | 1977 | https://conductscience.org/library/papers/908753 | PubMed |
| 11 | 4,561,619 | The pentose cycle and insulin release in mouse pancreatic islets. | Biochem J | 1972 | https://conductscience.org/library/papers/4561619 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24,876,415 | Selective allosteric antibodies to the insulin receptor for the treatment of hyperglycemic and hypoglycemic disorders. | J Diabetes Sci Technol | 2014 | https://conductscience.org/library/papers/24876415 | PubMed |
| 24,533,136 | Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity. | PLoS One | 2014 | https://conductscience.org/library/papers/24533136 | PubMed |
| 24,423,625 | Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: a potential new approach for the treatment of hyperinsulinemic hypoglycemia. | MAbs | 2014 | https://conductscience.org/library/papers/24423625 | PubMed |
| 22,403,294 | A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control. | Diabetes | 2012 | https://conductscience.org/library/papers/22403294 | PubMed |
| 7,046,731 | Receptor-mediated insulin degradation and insulin-stimulated glycogenesis in cultured foetal hepatocytes. | Biochem J | 1982 | https://conductscience.org/library/papers/7046731 | PubMed |
| 7,016,574 | Control of muscle insulin receptors by the motor nerve. | Experientia | 1981 | https://conductscience.org/library/papers/7016574 | PubMed |
| 7,000,825 | Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7000825 | PubMed |
| 6,998,797 | Internalization of polypeptide hormones: mechanism, intracellular localization and significance. | Diabetologia | 1980 | https://conductscience.org/library/papers/6998797 | PubMed |
| 6,989,695 | Characterization of insulin receptors in patients with the syndromes of insulin resistance and acanthosis nigricans. | Diabetologia | 1980 | https://conductscience.org/library/papers/6989695 | PubMed |
| 6,269,936 | A partial view of the mechanism of insulin action. | Diabetologia | 1981 | https://conductscience.org/library/papers/6269936 | PubMed |
1 to 10 of 21
See all 21 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| INSR | 3,643 | PubTator's text mining | https://conductscience.org/library/genes/3643 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/648762
GET https://conductscience.org/api/papers/v1/648762/cited_by?page=2